SCHEMBL6202385

SCHEMBL6202385

CC(C)O[C](OC(C)C)c1cccc(F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.48
CES1 P23141 2/20 0.48
KMT2A Q03164 3/20 0.46
LMNA P02545 2/20 0.46
MEN1 O00255 2/20 0.46
PARP1 P09874 1/20 0.46
PTGS1 P23219 2/20 0.44
PTGS2 P35354 2/20 0.44
ALDH1A1 P00352 2/20 0.43
CHRNB2 P17787 1/20 0.43
SLC6A2 P23975 1/20 0.43
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
CHRNA4 P43681 1/20 0.43
SLC6A3 Q01959 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8759589 0.81 NPC1 (0.56) CES2CES1KMT2ALMNAMEN1
SCHEMBL30678282 0.81 NPC1 (0.56) CES2CES1KMT2ALMNAMEN1
SCHEMBL6203342 0.77 SMN1; SMN2 (0.46) LMNAPARP1ALDH1A1CHRNB2SLC6A2
SCHEMBL6204823 0.76 CES2 (0.56) CES2CES1KMT2AMEN1PARP1
SCHEMBL6202384 0.75 NPC1 (0.42) CES2CES1KMT2ALMNAMEN1
SCHEMBL27406895 0.75 NPC1 (0.50) CES2CES1KMT2ALMNAMEN1
SCHEMBL7475311 0.74 NPC1 (0.49) CES2CES1KMT2ALMNAMEN1
SCHEMBL28469730 0.73 CES2 (0.45) CES2CES1KMT2ALMNAMEN1
SCHEMBL14415748 0.72 HPGD (0.48) CES2CES1KMT2ALMNAMEN1
SCHEMBL15904328 0.72 ADRB2 (0.53) CES2CES1KMT2ALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed